Inquiry into disgraced surgeon to hold preliminary hearing next month
The Eljamel Inquiry will investigate the activities and oversight of Mr Eljamel, who was appointed by NHS Tayside as a consultant neurosurgeon at Ninewells Hospital in Dundee in 1995 and went on to become head of neurosurgery at the site.
In 2013, Eljamel was placed under supervision and later suspended following concerns about the standard of clinical care he was providing to patients.
He resigned from NHS Tayside in 2014.
Patients of the former neurosurgeon have claimed he harmed as many as 200 people, with some suffering life-changing injuries.
The Eljamel Inquiry will determine, among other things, whether patients were let down by failures in clinical governance, risk management, and complaints procedures, and the adequacy of previous reviews.
It will also examine to what extent Eljamel's private practice, research, and workload impacted on care received by his patients, and whether, and if so to what extent, Eljamel and NHS Tayside tried to conceal evidence of sub-standard care. STV News Public inquiry launched into disgraced surgeon Eljamel
The independent public inquiry, chaired by Lord Weir, will hold a preliminary hearing in Edinburgh on September 10 to set out its progress and intentions.
Scotland's health secretary Neil Gray formally set up the inquiry on April 3, empowering it to begin the process of gathering evidence.
To date, Lord Weir has designated applicants including NHS Tayside, 133 former patients of Mr Eljamel and 19 personal representatives of former patients. This group is represented by the legal firm Levy & McRae.
The Scottish Government and the University of Dundee are also designated as core participants, as are the Royal College of Surgeons (Edinburgh), Healthcare Improvement Scotland, and NHS Education for Scotland.
Members of the public, including former patients, can apply to attend the preliminary hearing in person.
Proceedings will also be broadcast live on the inquiry's YouTube channel, and will be available to view later on its website.
The preliminary hearing will take place at Waverley Gate in central Edinburgh.
A spokesperson for NHS Tayside said: 'We are actively participating in the Eljamel Inquiry.'
Get all the latest news from around the country Follow STV News
Scan the QR code on your mobile device for all the latest news from around the country
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
STV News
37 minutes ago
- STV News
AI designs drugs to combat gonorrhoea and MRSA
Artificial intelligence has helped researchers to design antibiotics that can tackle hard-to-treat infections gonorrhoea and MRSA. A team at Massachusetts Institute of Technology used AI algorithms to design more than 36 million possible compounds and screen them for antimicrobial properties. The top candidates appeared to be different from any existing antibiotics, and researchers say they work through mechanisms that disrupt bacterial cell membranes. The use of AI allowed scientists to generate and test compounds that had never been seen before. Senior author of the study Professor James Collins said the team is 'excited' about the new possibilities opened up by this project. 'Our work shows the power of AI from a drug design standpoint, and enables us to exploit much larger chemical spaces that were previously inaccessible,' he said. The team used generative AI algorithms to design molecules based on a specific chemical fragment that showed antimicrobial activity, but they then also let the algorithms freely generate molecules that didn't require that specific fragment. Bacterial resistance to many antibiotics is also increasing – nearly five million deaths each year are caused by drug-resistant bacterial infections. 'We wanted to get rid of anything that would look like an existing antibiotic, to help address the antimicrobial resistance crisis in a fundamentally different way,' lead author Aarti Krishnan said. 'By venturing into underexplored areas of chemical space, our goal was to uncover novel mechanisms of action.' It is rare that new antibiotics are discovered and later approved by health authorities. Get all the latest news from around the country Follow STV News Scan the QR code on your mobile device for all the latest news from around the country
STV News
2 hours ago
- STV News
Price of 'life-changing' weight loss drug could triple within weeks
The price of a 'life-changing' weight loss drug could double or even triple in the UK by the end of the month, prompting fears that it will push more people into the black market. The manufacturers of Mounjaro announced overnight on Thursday that the UK price for the medication could increase by up to 170% from September 1. Manufacturer Eli Lilly said the increase will bring the price of the drug in the UK more in line with other countries. Ailish Jamieson, from Glasgow, is one of thousands of Scots taking the drug to improve her health and quality of life. After being on steroid medication for ten years, she said her BMI had gone up to 46. She said she was morbidly obese and struggling to lose weight on her own. STV News Ailish Jamieson lost ten stone on Mounjaro. 'It's given me a new lease in life,' Ms Jamieson said. 'I climbed Ben Nevis. I would never in a million years have been able to do that before.' Ms Jamieson, who already pays £160 a month for the medication, is now concerned that the price increases are going to make the medication inaccessible to many people. She said: 'I feel very privileged that I've been able to pay for this medication. 'Now I fell like… should you be able to put a price on living a healthy life?' Jackie Partridge, clinical director at Dermal Clinic in Edinburgh, agrees that the cost increases are going to have a big impact. With more than half a million people across the UK taking Mounjaro, Ms Partridge has branded the price increases 'really worrying'. 'Ultimately, people who have chosen to go on this after a full medical assessment [have done so] because it's improving their quality of life and health. To then have an even bigger barrier put in the way with pricing I think is really sad.' Heather Stringer, from Kincardine, is also worried about the price increases. The 41-year-old used Mounjaro to lose more than nine stone, and she's still on the medication to manage her obesity and other related symptoms. STV News Heather Stringer lost nine stone on Mounjaro. 'I'm going to really need to rethink that now, and rethink whether I need to come off the medication,' she said. 'It's already a huge financial undertaking as a mum with two kids. Now, it's going to be even more of a stretch and think it'll be the case for a lot of people.' She added: 'It's been lifechanging and I don't say that lightly. It's given me confidence, but it's also changed my health outcomes. Undoubtedly, I think I've added years to my life taking this medication.' But she said the 'massive' price rises are going to send more people into the black market. 'That is really risky,' she added. Get all the latest news from around the country Follow STV News Scan the QR code on your mobile device for all the latest news from around the country
STV News
11 hours ago
- STV News
Inquiry into disgraced surgeon to hold preliminary hearing next month
A public inquiry set up to investigate disgraced surgeon Sam Eljamel will hold a preliminary hearing next month. The Eljamel Inquiry will investigate the activities and oversight of Mr Eljamel, who was appointed by NHS Tayside as a consultant neurosurgeon at Ninewells Hospital in Dundee in 1995 and went on to become head of neurosurgery at the site. In 2013, Eljamel was placed under supervision and later suspended following concerns about the standard of clinical care he was providing to patients. He resigned from NHS Tayside in 2014. Patients of the former neurosurgeon have claimed he harmed as many as 200 people, with some suffering life-changing injuries. The Eljamel Inquiry will determine, among other things, whether patients were let down by failures in clinical governance, risk management, and complaints procedures, and the adequacy of previous reviews. It will also examine to what extent Eljamel's private practice, research, and workload impacted on care received by his patients, and whether, and if so to what extent, Eljamel and NHS Tayside tried to conceal evidence of sub-standard care. STV News Public inquiry launched into disgraced surgeon Eljamel The independent public inquiry, chaired by Lord Weir, will hold a preliminary hearing in Edinburgh on September 10 to set out its progress and intentions. Scotland's health secretary Neil Gray formally set up the inquiry on April 3, empowering it to begin the process of gathering evidence. To date, Lord Weir has designated applicants including NHS Tayside, 133 former patients of Mr Eljamel and 19 personal representatives of former patients. This group is represented by the legal firm Levy & McRae. The Scottish Government and the University of Dundee are also designated as core participants, as are the Royal College of Surgeons (Edinburgh), Healthcare Improvement Scotland, and NHS Education for Scotland. Members of the public, including former patients, can apply to attend the preliminary hearing in person. Proceedings will also be broadcast live on the inquiry's YouTube channel, and will be available to view later on its website. The preliminary hearing will take place at Waverley Gate in central Edinburgh. A spokesperson for NHS Tayside said: 'We are actively participating in the Eljamel Inquiry.' Get all the latest news from around the country Follow STV News Scan the QR code on your mobile device for all the latest news from around the country
